Our Stock of the Week is Hinge Health, Inc. (HNGE). Hinge Health is a digital healthcare company that provides virtual physical therapy and wearable technology to help patients manage chronic, acute, or post-surgical back, joint, and muscle pain from home, primarily through employer and health plan partnerships.
After trending lower into the end of 2025 and seeing a sharp decline in January, HNGE began making solid progress off lows in February after reporting Q4 2025 earnings of $0.49 per share (vs. est. $0.14) on revenue of $170.7 million, up 46% year-over-year. Shares broke past descending resistance on heavy volume in May after the company reported that Q1 2026 revenue grew 47% year-over-year, that same month rolling out its FDA-cleared Migraine Care Program, which has since signed up more than 125 self-insured employers and health plans covering over two million participants.
The stock continued to work higher before accelerating sharply in July, surging from the mid-$60s to nearly $90 in a matter of weeks as the company hosted its inaugural Investor Day where management raised guidance again, which, in turn, drew a wave of price target increases.
HNGE pulled back from overbought territory later that month but found support at the 50dma before bouncing back to highs earlier this month after the company reported Q2 2026 revenue of $212.8 (vs. est. $201.5 million) and announced a $105 million acquisition of Cylinder Health, expanding the platform beyond musculoskeletal care into gastrointestinal health, a category representing roughly $135 billion in annual medical spend. 8 analysts increased their price targets, including Truist to $112, Evercore ISI to $105, and RBC Capital to $110 following the report.
Since then, HNGE has been flagging at highs with support at the 20dma and could be building cause for another leg higher. As always, we will not chase any early strength on Monday morning, but will look to aggressively trade the stock as the chart develops.
Interested in learning about how we help clients build long-term wealth and not end up being a charity to the IRS in the process? Click here to invest with RevShark, and let’s explore the how we can to make a significant impact on your results.
This post is for educational purposes only! This is not advice or a recommendation. We do not give investment advice. Do not act on this post. Do not buy, sell, or trade the stocks mentioned herein. We WILL actively trade this stock differently than discussed herein. We will sell into strength and buy or sell at any time for any reason. We will actively trade into any unusual activity. At the time of this post, principals, employees, and affiliates of Shark Investing, Inc. and/or principals, clients, employees, and affiliates of Hammerhead Financial Strategies, LLC, directly or indirectly, controlled investment and/or trading accounts containing positions in HNGE at the time this was published. To accommodate the objectives of these investing and/or trading accounts, the trading in these shares will be contrary to and/or inconsistent with the information contained in this posting.
